BioLineRx Ltd. ( BLRX) - Stock Earnings
BLRX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 13, 2026, midnight | — / — | — | — / — | — |
BLRX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -977000 USD | 427000 USD |
| 2025Q4 | -1.4 million USD | 195211 USD |
| 2026Q1 | -2.6 million USD | 477000 USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
BLRX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -60.6 million USD | 4.8 million USD |
| 2024 | -9.2 million USD | 28.9 million USD |
| 2025 | -1.2 million USD | 1.2 million USD |
| 2026 Est. | — | — |
BLRX
Price: $2.76
52 week price:
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 323100
Ebitda: -7.1 millionMarket Capitalization: 12.1 million